Výsledky vyhledávání - "H.A. Hou"

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: HIGH BM PLASMA S100A8/A9 IS ASSOCIATED WITH A PERTURBED MICROENVIRONMENT AND POOR PROGNOSIS IN MYELODYSPLASTIC SYNDROMES

Autor: Y.-H. Wang, C.C. Lin, C.-Y. Yao, H.A. Hou, W.C. Chou, H.F. Tien

Publikováno v: Leukemia Research. 128:107234

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b190935d48354d54b0777790dd8fc613
https://doi.org/10.1016/j.leukres.2023.107234

Zobrazit plný text záznamu

Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): CLINICO-GENETIC AND PROGNOSTIC ANALYSES OF 716 PATIENTS WITH PRIMARY MDS AND MDS/AML BASED ON THE 2022 INTERNATIONAL CONSENSUS CLASSIFICATION

Autor: S.-C. Ni, W.-H. Lee, M.Y. Lo, C.H. Tsai, C.C. Lin, F.M. Tien, M. Yao, J.L. Tang, Y.Y. Kuo, M.-C. Liu, Y.K. Chuang, M.H. Tseng, W.C. Chou, H.A. Hou, H.F. Tien

Publikováno v: Leukemia Research. 128:107151

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c8e19bfe998b178ad729809c651a7b38
https://doi.org/10.1016/j.leukres.2023.107151

Zobrazit plný text záznamu

Topic: AS04-MDS Biology and Pathogenesis/AS04g-Epigenetic deregulation: SINGLE CELL PROTEOMICS IDENTIFIES DISTINCT EPIGENETIC PERTURBATIONS AND BIOMARKERS TO PREDICT RESPONSIVENESS TO AZACITIDINE IN MDS AND AML

Autor: F.M. Tien, H.A. Hou, W.C. Chou, H.C. Tsai, H.F. Tien

Publikováno v: Leukemia Research. 128:107203

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c6bd945b5e6ba22dadce063e1236cfec
https://doi.org/10.1016/j.leukres.2023.107203

Zobrazit plný text záznamu

Clinical Implications of the SETBP1 Mutation in Patients With Primary Myelodysplastic Syndrome and its Stability During Disease Progression

Autor: H.A. Hou, Y.Y. Kuo, J.L. Tang, W.W. Chou, M. Yao, Y.L. Lai, C.C. Lin, C.Y. Chen, C.Y. Liu, M.C. Lee, M.H. Tseng, C.F. Huang, Y.C. Chiang, F.Y. Lee, M.C. Liu, S.Y. Huang, B.S. Ko, S.J. Wu, W. Tsay, Y.C. Chen, H.F. Tien

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 14:S153

Mutations of the SET binding protein 1 (SETBP1) gene have been identified in patients with myeloid neoplasms, but the clinical relevance of this mutation and its association with other gene mutations in myelodysplastic syndrome (MDS) and the stabilit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cee2a6a2891162a8d96d95e60becfb7a
https://doi.org/10.1016/j.clml.2014.06.095

Zobrazit plný text záznamu